Screening for hypertrophic cardiomyopathy.
- 13 February 1993
- Vol. 306 (6875) , 409-410
- https://doi.org/10.1136/bmj.306.6875.409
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.Circulation, 1992
- Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathyHeart, 1992
- Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic CardiomyopathyNew England Journal of Medicine, 1992
- Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy.Circulation, 1992
- Preclinical Diagnosis of Familial Hypertrophic Cardiomyopathy by Genetic Analysis of Blood LymphocytesNew England Journal of Medicine, 1991
- Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathyThe American Journal of Cardiology, 1991
- Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.Heart, 1985
- Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic featuresThe American Journal of Cardiology, 1981
- Sudden death in young athletes.Circulation, 1980
- Familial Prevalence and Genetic Transmission of Idiopathic Hypertrophic Subaortic StenosisNew England Journal of Medicine, 1973